US · CENTA · PACKAGED FOODS
Central Garden & Pet Company (CENTA) intrinsic value and stock valuation
$39.60as of 2026-11-21 · Mkt cap 2.76B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Central Garden & Pet Company DCF and intrinsic value
InvestorsCraft values CENTA with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from CENTA’s statements →
Central Garden & Pet Company Graham Number
Graham Number: $38.19d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.13B | $3.2B | $3.31B | $3.34B | $3.3B |
| Operating income | $265.1M | $185.4M | $210.7M | $260M | $257.1M |
| Net income | $162.8M | $108M | $125.6M | $152.2M | $151.8M |
| EPSd | $2.55M | $1.62M | $2.35M | $2.8M | $2.75M |
| Operating cash flow | $332.5M | $394.9M | $381.6M | -$-34.03M | $250.8M |
| Capital expenditure | -$-41.42M | -$-43.13M | -$-53.97M | -$-115.2M | -$-80.33M |
| Free cash flow | $291.1M | $351.8M | $327.7M | -$-149.24M | $170.5M |
| Total assets | $3.63B | $3.55B | $3.38B | $3.28B | $3.12B |
| Total debt | $1.44B | $1.42B | $1.37B | $1.38B | $1.36B |
| Net debt | $557.8M | $666.9M | $885.7M | $1.2B | $930.2M |
| Total equity | $1.58B | $1.56B | $1.45B | $1.33B | $1.22B |
| Cash and short-term investments | $882.5M | $753.6M | $488.7M | $177.4M | $426.4M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.13B | $3.2B | $3.31B | $3.34B | $3.3B |
| Cost of revenue | $2.16B | $2.26B | $2.36B | $2.35B | $2.33B |
| Gross profit | $972.8M | $943.7M | $946.8M | $992.3M | $970.9M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $707.8M | $703.4M | $736.2M | $732.3M | $716.4M |
| Other expenses | $0.00 | $55M | $0.00 | $0.00 | $0.00 |
| Operating expenses | $707.8M | $758.4M | $736.2M | $732.3M | $716.4M |
| Cost and expenses | $2.86B | $3.02B | $3.1B | $3.08B | $3.05B |
| Interest income | $24.9M | $19.7M | $7.36M | $720K | $410K |
| Interest expense | $57.7M | $57.5M | $57M | $58.3M | $58.6M |
| Depreciation and amortization | $84.9M | $90.8M | $87.7M | $129.6M | $115.8M |
| Ebitda | $359.3M | $290.8M | $307.2M | $386.8M | $366.7M |
| Operating income | $265.1M | $185.4M | $210.7M | $260M | $257.1M |
| Total other income/expenses, net | -$-48.3M | -$-42.96M | -$-48.2M | -$-61.13M | -$-62.3M |
| Income before tax | $216.8M | $142.4M | $162.4M | $198.9M | $194.8M |
| Income tax expense | $52.8M | $33.1M | $36.4M | $46.2M | $42M |
| Net income | $162.8M | $108M | $125.6M | $152.2M | $151.8M |
| Weighted average shares outstanding | $63.1M | $65.7M | $53.5M | $53.2M | $53.9M |
| Weighted average diluted shares outstanding | $63.8M | $66.9M | $53.4M | $54.4M | $55.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $882.5M | $753.6M | $488.7M | $177.4M | $426.4M |
| Net receivables | $325.3M | $326.2M | $332.9M | $376.8M | $385.4M |
| Inventory | $722.1M | $757.9M | $838.2M | $938M | $685.2M |
| Total current assets | $1.98B | $1.89B | $1.71B | $1.55B | $1.54B |
| Property, plant and equipment, net | $586.1M | $584.3M | $565.3M | $583.3M | $494.2M |
| Goodwill and intangible assets | $1B | $1.02B | $1.04B | $1.09B | $503.8M |
| Long-term investments | $30.5M | $31.5M | $38.7M | $38.5M | $12.2M |
| Total non-current assets | $1.65B | $1.67B | $1.67B | $1.73B | $1.57B |
| Total assets | $3.63B | $3.55B | $3.38B | $3.28B | $3.12B |
| Accounts payable | $234.6M | $212.6M | $190.9M | $215.7M | $245.5M |
| Short-term debt | $56.9M | $57.6M | $50.8M | $48.4M | $41.8M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $538.8M | $515.4M | $458M | $465.9M | $522.3M |
| Long-term debt | $1.38B | $1.36B | $1.32B | $1.33B | $1.31B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $1.5B | $1.48B | $1.47B | $1.48B | $1.37B |
| Capital lease obligations | $248.6M | $230.4M | $186.2M | $195.8M | $170.9M |
| Total liabilities | $2.04B | $2B | $1.93B | $1.95B | $1.89B |
| Common stock | $630K | $110K | $540K | $540K | $550K |
| Retained earnings | $1.02B | $959.5M | $859.4M | $755.3M | $646.1M |
| Accumulated other comprehensive income (loss) | -$-3.85M | -$-2.63M | -$-2.97M | -$-4.14M | -$-830K |
| Total equity | $1.58B | $1.56B | $1.45B | $1.33B | $1.22B |
| Total investments | $30.5M | $31.5M | $38.7M | $38.5M | $12.2M |
| Total debt | $1.44B | $1.42B | $1.37B | $1.38B | $1.36B |
| Net debt | $557.8M | $666.9M | $885.7M | $1.2B | $930.2M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $164M | $109.3M | $126.1M | $152.7M | $152.8M |
| Depreciation and amortization | $84.9M | $90.8M | $87.7M | $81M | $74.7M |
| Stock-based compensation | $21.1M | $20.6M | $28M | $25.8M | $23.1M |
| Change in working capital | -$-10.88M | $80.8M | $87.5M | -$-372.43M | -$-43.94M |
| Accounts receivable | $630K | $11.9M | $44M | $7M | $69.1M |
| Inventory | $31.3M | $84.3M | $87M | -$-256.44M | -$-132.17M |
| Accounts payable | $20.1M | $18.4M | -$-19.96M | -$-31.21M | $24.6M |
| Net cash provided by operating activities | $332.5M | $394.9M | $381.6M | -$-34.03M | $250.8M |
| Investments in property, plant and equipment | -$-41.42M | -$-43.13M | -$-53.97M | -$-115.2M | -$-80.33M |
| Acquisitions, net | -$-3.32M | -$-60.23M | $20M | $0.00 | -$-818.05M |
| Net cash used for investing activities | -$-44.89M | -$-105.19M | -$-34.58M | -$-142.98M | -$-899.36M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-155.07M | -$-24.07M | -$-37.16M | -$-62.29M | -$-27.89M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-156.64M | -$-25.44M | -$-37.55M | -$-66.81M | $420.5M |
| Net change in cash | $130M | $265.5M | $310.7M | -$-247.34M | -$-226.88M |
| Cash at end of period | $898.4M | $768.4M | $502.9M | $192.2M | $439.5M |
| Operating cash flow | $332.5M | $394.9M | $381.6M | -$-34.03M | $250.8M |
| Capital expenditure | -$-41.42M | -$-43.13M | -$-53.97M | -$-115.2M | -$-80.33M |
| Free cash flow | $291.1M | $351.8M | $327.7M | -$-149.24M | $170.5M |
Line items
Line items
Line items
About Central Garden & Pet Company
Central Garden & Pet Company (CENTA) is a prominent U.S.-based enterprise specializing in the manufacturing and distribution of a wide array of products for both the lawn and garden and pet supply sectors. Its operations are strategically divided into two primary divisions: Pet and Garden. The Pet segment caters to a diverse range of animal companions, offering everything from essential dog and cat provisions—such as treats, chews, toys, beds, grooming aids, waste management solutions, and containment systems—to specialized items for aquatics, small animals, reptiles, and pet birds. For these smaller creatures, products include cages, habitats, bedding, food, and nutritional supplements. Furthermore, this segment addresses animal and household health with insect control solutions, and provides comprehensive supplies for live fish and other aquarium inhabitants, encompassing tanks, furniture, lighting, pumps, filters, water conditioners, and various food and supplement options. It also extends its offerings to horses and livestock, and even includes outdoor cushions and pillows. Key brands within this segment feature well-known names such as Aqueon, Cadet, Comfort Zone, Farnam, Four Paws, Kaytee, K&H Pet Products, Nylabone, and Zilla. The Garden division supplies an extensive catalog of lawn and garden necessities. This includes grass seed, a variety of wild bird products (feed, feeders, houses, and accessories), fertilizers, decorative outdoor lifestyle items, and live plants. Additionally, it provides solutions for pest and weed control, offering herbicides, insecticides, and other pesticide products. Notable brands under the Garden segment are AMDRO, Ferry-Morse, Pennington, and Sevin, alongside others like Bell Nursery, Lilly Miller, and Over-N-Out. Established in 1955, Central Garden & Pet Company maintains its corporate headquarters in Walnut Creek, California.
- CEO
- Nicholas Lahanas
- Employees
- 6K
- Beta
- 0.57
Included in
Explore
Frequently asked questions
What is the intrinsic value of Central Garden & Pet Company (CENTA)?
Central Garden & Pet Company (CENTA) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is CENTA undervalued?
CENTA trades at a price of $39.60 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.